Background: A small randomized controlled trial suggested that dabigatran may be as
effective as warfarin in the treatment of cerebral venous thrombosis (CVT). We aimed to …

Background: High level evidence for direct oral anticoagulants (DOACs) in patients with
cerebral venous thrombosis is lacking. We performed a systematic review and meta-analysis …

Background: Due to the rarity of cerebral venous thrombosis (CVT), performing high-quality
scientific research in this field is challenging. Providing answers to unresolved research …

This is the second European Crohn's and Colitis Organisation [ECCO] evidence-based
consensus on extraintestinal manifestations [EIMs] of inflammatory bowel disease [IBD] and …

Deep Vein Thrombosis - Abstract - Europe PMC Sign in | Create an account https://orcid.org
Europe PMC Menu About Tools Developers Help Contact us Helpdesk Feedback Twitter Blog …

Introduction Current guidelines recommend that patients with cerebral venous thrombosis
(CVT) should be treated with vitamin K antagonists (VKAs) for 3–12 months. Direct oral …

Cerebral venous thrombosis (CVT) is a rare form of stroke that often affects younger age
groups, especially reproductive age group females. CVT is a potentially fatal neurological …

We aimed to investigate the efficacy and safety of rivaroxaban for acute and long-term
management of cerebral venous sinus thrombosis (CVST). This study reviewed CVST …

The evolution of the Coronavirus Disease-2019 pandemic and its vaccination raised more
attention to cerebral venous thrombosis (CVT). Although CVT is less prevalent than arterial …

Cerebral venous sinus thrombosis (CVT) consists of partial or complete occlusion of a sinus
or a cerebral vein. CVT represents 0.5-1% of all strokes and is more frequent in young …